Share Price and Basic Stock Data
Last Updated: March 6, 2026, 3:19 am
| PEG Ratio | 0.29 |
|---|
📊 Last updated
11d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ugro Capital Ltd operates in the finance and investments sector, showcasing robust growth in revenue. The company’s revenue recorded a substantial increase from ₹312 Cr in March 2022 to ₹684 Cr in March 2023, marking a growth of 119%. For the fiscal year ending March 2025, revenue is anticipated to reach ₹1,396 Cr, further demonstrating the company’s upward trajectory. Quarterly performance reflects this trend, with revenue rising from ₹149 Cr in September 2022 to ₹245 Cr by September 2023. The company has maintained a consistent increase in revenue through effective financial strategies. Additionally, financing profit has shown a positive evolution, standing at ₹204 Cr for the year ending March 2025, indicating improved operational efficiency. The financing margin has fluctuated but remained competitive, at 15% for March 2025. Overall, Ugro Capital’s revenue trends highlight a strong growth trajectory within the financial services industry, positioning it favorably against sector peers.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Ugro Capital Ltd | 1,627 Cr. | 105 | 196/101 | 13.1 | 159 | 0.00 % | 11.0 % | 8.26 % | 10.0 |
| Geojit Financial Services Ltd | 1,717 Cr. | 61.5 | 94.8/59.0 | 17.3 | 41.8 | 2.44 % | 18.8 % | 16.8 % | 1.00 |
| Rane Holdings Ltd | 1,731 Cr. | 1,212 | 1,835/1,135 | 85.4 | 786 | 3.14 % | 9.64 % | 8.02 % | 10.0 |
| PTC India Financial Services Ltd | 1,847 Cr. | 28.8 | 44.5/27.2 | 5.53 | 46.4 | 0.00 % | 9.93 % | 8.20 % | 10.0 |
| PNB Gilts Ltd | 1,386 Cr. | 77.0 | 120/73.6 | 5.72 | 91.2 | 1.30 % | 6.80 % | 16.1 % | 10.0 |
| Industry Average | 7,126.05 Cr | 1,177.33 | 106.23 | 4,366.08 | 0.39% | 21.71% | 14.20% | 7.23 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 181.74 | 208.97 | 213.27 | 244.57 | 267.71 | 322.41 | 291.44 | 330.16 | 371.12 | 403.18 | 414.00 | 455.40 | 408.88 |
| Interest | 81.59 | 90.37 | 92.69 | 105.40 | 116.70 | 128.14 | 136.15 | 143.10 | 167.31 | 181.21 | 205.37 | 218.55 | 236.55 |
| Expenses | 80.88 | 86.90 | 82.47 | 98.66 | 107.13 | 136.41 | 112.65 | 138.94 | 152.19 | 160.78 | 155.51 | 167.39 | 188.10 |
| Financing Profit | 19.27 | 31.70 | 38.11 | 40.51 | 43.88 | 57.86 | 42.64 | 48.12 | 51.62 | 61.19 | 53.12 | 69.46 | -15.77 |
| Financing Margin % | 10.60% | 15.17% | 17.87% | 16.56% | 16.39% | 17.95% | 14.63% | 14.57% | 13.91% | 15.18% | 12.83% | 15.25% | -3.86% |
| Other Income | 7.84 | 8.19 | 5.08 | 9.06 | 11.60 | 7.98 | 10.13 | 12.71 | 13.84 | 9.26 | 7.83 | 5.78 | 39.45 |
| Depreciation | 4.89 | 6.23 | 7.55 | 8.77 | 9.11 | 9.90 | 9.95 | 10.71 | 12.49 | 13.24 | 12.78 | 14.14 | 13.99 |
| Profit before tax | 22.22 | 33.66 | 35.64 | 40.80 | 46.37 | 55.94 | 42.82 | 50.12 | 52.97 | 57.21 | 48.17 | 61.10 | 9.69 |
| Tax % | 41.00% | 58.29% | 29.21% | 29.17% | 29.87% | 41.58% | 29.15% | 29.11% | 29.19% | 29.14% | 29.15% | 29.12% | 34.16% |
| Net Profit | 13.12 | 14.04 | 25.24 | 28.89 | 32.53 | 32.69 | 30.36 | 35.52 | 37.51 | 40.55 | 34.13 | 43.31 | 6.38 |
| EPS in Rs | 1.47 | 1.57 | 2.16 | 2.47 | 2.78 | 2.78 | 2.58 | 3.02 | 3.18 | 3.44 | 2.92 | 3.71 | 0.41 |
| Gross NPA % | 1.70% | 2.46% | 1.80% | 1.90% | 2.00% | 2.00% | 2.00% | 2.10% | 2.10% | 2.30% | 2.50% | 2.40% | 2.20% |
| Net NPA % | 1.10% | 1.31% | 1.00% | 1.10% | 1.10% | 1.10% | 1.20% | 1.30% | 1.50% | 1.60% | 1.70% | 1.50% | 1.40% |
Last Updated: March 3, 2026, 2:04 pm
Below is a detailed analysis of the quarterly data for Ugro Capital Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Interest, as of Dec 2025, the value is 236.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 218.55 Cr. (Sep 2025) to 236.55 Cr., marking an increase of 18.00 Cr..
- For Expenses, as of Dec 2025, the value is 188.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 167.39 Cr. (Sep 2025) to 188.10 Cr., marking an increase of 20.71 Cr..
- For Other Income, as of Dec 2025, the value is 39.45 Cr.. The value appears strong and on an upward trend. It has increased from 5.78 Cr. (Sep 2025) to 39.45 Cr., marking an increase of 33.67 Cr..
- For Depreciation, as of Dec 2025, the value is 13.99 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.14 Cr. (Sep 2025) to 13.99 Cr., marking a decrease of 0.15 Cr..
- For Profit before tax, as of Dec 2025, the value is 9.69 Cr.. The value appears to be declining and may need further review. It has decreased from 61.10 Cr. (Sep 2025) to 9.69 Cr., marking a decrease of 51.41 Cr..
- For Tax %, as of Dec 2025, the value is 34.16%. The value appears to be increasing, which may not be favorable. It has increased from 29.12% (Sep 2025) to 34.16%, marking an increase of 5.04%.
- For Net Profit, as of Dec 2025, the value is 6.38 Cr.. The value appears to be declining and may need further review. It has decreased from 43.31 Cr. (Sep 2025) to 6.38 Cr., marking a decrease of 36.93 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.41. The value appears to be declining and may need further review. It has decreased from 3.71 (Sep 2025) to 0.41, marking a decrease of 3.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 26, 2026, 6:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 2 | 4 | 2 | 4 | 44 | 105 | 153 | 312 | 684 | 1,082 | 1,396 | 1,681 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 45 | 137 | 293 | 443 | 628 | 842 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 36 | 81 | 85 | 142 | 289 | 425 | 565 | 672 |
| Financing Profit | 5 | 2 | 3 | 2 | 3 | 7 | 11 | 24 | 33 | 101 | 214 | 204 | 168 |
| Financing Margin % | 86% | 76% | 92% | 86% | 91% | 16% | 10% | 16% | 10% | 15% | 20% | 15% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 46 | 62 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 12 | 12 | 18 | 35 | 46 | 54 |
| Profit before tax | 5 | 2 | 3 | 2 | 3 | 2 | 3 | 12 | 20 | 84 | 179 | 203 | 176 |
| Tax % | 30% | 7% | 14% | 2% | 8% | -155% | -488% | -137% | 28% | 53% | 33% | 29% | |
| Net Profit | 4 | 2 | 3 | 2 | 3 | 4 | 20 | 29 | 15 | 40 | 119 | 144 | 124 |
| EPS in Rs | 6.41 | 2.83 | 5.07 | 3.34 | 5.05 | 1.34 | 2.19 | 3.22 | 1.63 | 4.46 | 10.17 | 12.22 | 10.48 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 50.00% | -33.33% | 50.00% | 33.33% | 400.00% | 45.00% | -48.28% | 166.67% | 197.50% | 21.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -83.33% | 83.33% | -16.67% | 366.67% | -355.00% | -93.28% | 214.94% | 30.83% | -176.49% |
Ugro Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 89% |
| 5 Years: | 68% |
| 3 Years: | 65% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 49% |
| 3 Years: | 115% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 14% |
| 3 Years: | -2% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 23 | 71 | 71 | 71 | 69 | 92 | 92 | 114 |
| Reserves | 23 | 25 | 27 | 29 | 32 | 796 | 851 | 882 | 896 | 915 | 1,347 | 1,954 | 2,349 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 24 | 255 | 766 | 1,802 | 3,149 | 4,653 | 6,904 | 8,088 |
| Other Liabilities | 1 | 0 | 0 | 0 | 0 | 26 | 36 | 37 | 86 | 173 | 188 | 218 | 228 |
| Total Liabilities | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 | 10,779 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 20 | 38 | 36 | 56 | 85 | 130 | 168 | 190 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 4 | 6 | 14 | 0 | 0 | 0 |
| Investments | 26 | 15 | 25 | 26 | 36 | 107 | 73 | 55 | 69 | 60 | 59 | 103 | 492 |
| Other Assets | 3 | 14 | 8 | 8 | 1 | 731 | 1,101 | 1,659 | 2,724 | 4,146 | 6,091 | 8,897 | 10,098 |
| Total Assets | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 | 10,779 |
Below is a detailed analysis of the balance sheet data for Ugro Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2025) to 114.00 Cr., marking an increase of 22.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,349.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,954.00 Cr. (Mar 2025) to 2,349.00 Cr., marking an increase of 395.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 228.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 218.00 Cr. (Mar 2025) to 228.00 Cr., marking an increase of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 10,779.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,168.00 Cr. (Mar 2025) to 10,779.00 Cr., marking an increase of 1,611.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 190.00 Cr.. The value appears strong and on an upward trend. It has increased from 168.00 Cr. (Mar 2025) to 190.00 Cr., marking an increase of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 492.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2025) to 492.00 Cr., marking an increase of 389.00 Cr..
- For Other Assets, as of Sep 2025, the value is 10,098.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,897.00 Cr. (Mar 2025) to 10,098.00 Cr., marking an increase of 1,201.00 Cr..
- For Total Assets, as of Sep 2025, the value is 10,779.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,168.00 Cr. (Mar 2025) to 10,779.00 Cr., marking an increase of 1,611.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 12.00 | -174.00 | -681.00 | 141.00 | 286.00 | 421.00 | 559.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 15% | 6% | 10% | 6% | 8% | 1% | 2% | 3% | 2% | 4% | 10% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.68 | 13.39 | 5.69 | 2.06 | 4.07 |
| Diluted EPS (Rs.) | 14.71 | 13.20 | 5.66 | 2.05 | 4.07 |
| Cash EPS (Rs.) | 20.70 | 16.89 | 8.28 | 3.81 | 5.74 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Revenue From Operations / Share (Rs.) | 151.82 | 114.42 | 94.70 | 43.55 | 21.24 |
| PBDIT / Share (Rs.) | 95.41 | 71.73 | 56.94 | 24.08 | 9.70 |
| PBIT / Share (Rs.) | 90.37 | 67.88 | 54.40 | 22.33 | 8.04 |
| PBT / Share (Rs.) | 22.09 | 19.52 | 12.09 | 2.86 | 1.72 |
| Net Profit / Share (Rs.) | 15.65 | 13.03 | 5.74 | 2.06 | 4.07 |
| PBDIT Margin (%) | 62.84 | 62.69 | 60.13 | 55.29 | 45.67 |
| PBIT Margin (%) | 59.52 | 59.32 | 57.44 | 51.27 | 37.84 |
| PBT Margin (%) | 14.55 | 17.05 | 12.76 | 6.56 | 8.09 |
| Net Profit Margin (%) | 10.31 | 11.38 | 6.05 | 4.73 | 19.17 |
| Return on Networth / Equity (%) | 7.03 | 8.29 | 4.04 | 1.50 | 3.01 |
| Return on Capital Employeed (%) | 38.12 | 20.96 | 17.06 | 9.25 | 4.50 |
| Return On Assets (%) | 1.56 | 1.90 | 0.92 | 0.50 | 1.64 |
| Long Term Debt / Equity (X) | 0.00 | 0.99 | 1.16 | 0.72 | 0.31 |
| Total Debt / Equity (X) | 3.37 | 3.24 | 3.20 | 1.86 | 0.80 |
| Asset Turnover Ratio (%) | 0.18 | 0.19 | 0.18 | 0.13 | 0.10 |
| Current Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Quick Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Interest Coverage Ratio (X) | 1.40 | 1.48 | 1.35 | 1.24 | 1.54 |
| Interest Coverage Ratio (Post Tax) (X) | 1.23 | 1.27 | 1.14 | 1.11 | 1.64 |
| Enterprise Value (Cr.) | 7869.00 | 6209.26 | 3942.28 | 2792.18 | 1301.28 |
| EV / Net Operating Revenue (X) | 5.64 | 5.92 | 6.01 | 9.09 | 8.69 |
| EV / EBITDA (X) | 8.97 | 9.45 | 9.99 | 16.43 | 19.02 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| Price / BV (X) | 0.73 | 1.40 | 1.02 | 1.22 | 0.89 |
| Price / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| EarningsYield | 0.09 | 0.05 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Ugro Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has increased from 13.39 (Mar 24) to 15.68, marking an increase of 2.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.71. This value is within the healthy range. It has increased from 13.20 (Mar 24) to 14.71, marking an increase of 1.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 20.70. This value is within the healthy range. It has increased from 16.89 (Mar 24) to 20.70, marking an increase of 3.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.82. It has increased from 114.42 (Mar 24) to 151.82, marking an increase of 37.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 95.41. This value is within the healthy range. It has increased from 71.73 (Mar 24) to 95.41, marking an increase of 23.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 90.37. This value is within the healthy range. It has increased from 67.88 (Mar 24) to 90.37, marking an increase of 22.49.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.09. This value is within the healthy range. It has increased from 19.52 (Mar 24) to 22.09, marking an increase of 2.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.65. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 15.65, marking an increase of 2.62.
- For PBDIT Margin (%), as of Mar 25, the value is 62.84. This value is within the healthy range. It has increased from 62.69 (Mar 24) to 62.84, marking an increase of 0.15.
- For PBIT Margin (%), as of Mar 25, the value is 59.52. This value exceeds the healthy maximum of 20. It has increased from 59.32 (Mar 24) to 59.52, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 17.05 (Mar 24) to 14.55, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 10.31. This value exceeds the healthy maximum of 10. It has decreased from 11.38 (Mar 24) to 10.31, marking a decrease of 1.07.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 8.29 (Mar 24) to 7.03, marking a decrease of 1.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 38.12. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 38.12, marking an increase of 17.16.
- For Return On Assets (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has decreased from 1.90 (Mar 24) to 1.56, marking a decrease of 0.34.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.99 (Mar 24) to 0.00, marking a decrease of 0.99.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 1. It has increased from 3.24 (Mar 24) to 3.37, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 24) to 1.40, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 3. It has decreased from 1.27 (Mar 24) to 1.23, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,869.00. It has increased from 6,209.26 (Mar 24) to 7,869.00, marking an increase of 1,659.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.64. This value exceeds the healthy maximum of 3. It has decreased from 5.92 (Mar 24) to 5.64, marking a decrease of 0.28.
- For EV / EBITDA (X), as of Mar 25, the value is 8.97. This value is within the healthy range. It has decreased from 9.45 (Mar 24) to 8.97, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.73, marking a decrease of 0.67.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ugro Capital Ltd:
- Net Profit Margin: 10.31%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 38.12% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.1 (Industry average Stock P/E: 106.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.31%
About the Company - Qualitative Analysis
Ugro Capital Ltd. is a Public Limited Listed company incorporated on 10/02/1993 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L67120MH1993PLC070739 and registration number is 070739. Currently Company is involved in the business activities of Other financial service activities, except insurance and pension funding activities. Company's Total Operating Revenue is Rs. 1395.90 Cr. and Equity Capital is Rs. 91.95 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | Equinox Business Park, Mumbai Maharashtra 400070 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Satyananda Mishra | Non Exe.Chairman&Ind.Director |
| Mr. Shachindra Nath | Vice Chairman & Mng.Director |
| Mr. Karuppasamy Singam | Independent Director |
| Ms. Tabassum Abdulla Inamdar | Independent Director |
| Mr. Karnam Sekar | Independent Director |
| Mr. Hemant Bhargava | Independent Director |
| Mr. Rajeev K Agarwal | Independent Director |
| Mr. Suresh Eshwara Prabhala | Non Exe. & Nominee Director |
| Mr. Rohit Goyal | Non Exe. & Nominee Director |
| Mr. Chetan Gupta | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Ugro Capital Ltd?
Ugro Capital Ltd's intrinsic value (as of 10 March 2026) is ₹203.69 which is 93.99% higher the current market price of ₹105.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,627 Cr. market cap, FY2025-2026 high/low of ₹196/101, reserves of ₹2,349 Cr, and liabilities of ₹10,779 Cr.
What is the Market Cap of Ugro Capital Ltd?
The Market Cap of Ugro Capital Ltd is 1,627 Cr..
What is the current Stock Price of Ugro Capital Ltd as on 10 March 2026?
The current stock price of Ugro Capital Ltd as on 10 March 2026 is ₹105.
What is the High / Low of Ugro Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ugro Capital Ltd stocks is ₹196/101.
What is the Stock P/E of Ugro Capital Ltd?
The Stock P/E of Ugro Capital Ltd is 13.1.
What is the Book Value of Ugro Capital Ltd?
The Book Value of Ugro Capital Ltd is 159.
What is the Dividend Yield of Ugro Capital Ltd?
The Dividend Yield of Ugro Capital Ltd is 0.00 %.
What is the ROCE of Ugro Capital Ltd?
The ROCE of Ugro Capital Ltd is 11.0 %.
What is the ROE of Ugro Capital Ltd?
The ROE of Ugro Capital Ltd is 8.26 %.
What is the Face Value of Ugro Capital Ltd?
The Face Value of Ugro Capital Ltd is 10.0.